Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Buchanan

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Wiener Klinische Wochenschrift|March 27, 1999
A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleedingM R Buchanan, S J Brister
Journal of Cardiothoracic and Vascular Anesthesia|June 1, 1995
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfateS J Brister, M R Buchanan
The Canadian Journal of Cardiology|December 1, 2001
Sex-related differences in the pathophysiology of cardiovascular disease: is there a rationale for sex-related treatments?M R Buchanan, S J Brister
Thrombosis Research|April 1, 1994
Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivoD S Houston, M R Buchanan
Advances in Experimental Medicine and Biology|January 1, 1997
Effects of linoleic acid and/or marine fish oil supplements on vessel wall thromboresistance in patients undergoing cardiac surgeryS J Brister, M R Buchanan
Annals of the New York Academy of Sciences|January 1, 1982
Interactions of platelets and leukocytes with vascular endothelium: in vitro studiesM A Gimbrone, M R Buchanan
Advances in Experimental Medicine and Biology|January 1, 1997
Effects of 13-HODE and other momohydroxides on integrin/ligand binding: implications for cell cell interactionsM R Buchanan, S J Brister
Thrombosis Research|February 15, 1983
Basal 6 keto PGF1 alpha levels: influence of sampling techniquesR W Butt, M R Buchanan
Seminars in Thrombosis and Hemostasis|January 1, 1993
Altering vessel wall fatty acid metabolism: a new strategy for antithrombotic treatmentM R Buchanan, S J Brister
Thrombosis Research|September 7, 2000
Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonistM R Buchanan, S J Brister
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Wiener Klinische Wochenschrift|March 27, 1999
A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleedingM R Buchanan, S J Brister
Journal of Cardiothoracic and Vascular Anesthesia|June 1, 1995
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfateS J Brister, M R Buchanan
The Canadian Journal of Cardiology|December 1, 2001
Sex-related differences in the pathophysiology of cardiovascular disease: is there a rationale for sex-related treatments?M R Buchanan, S J Brister
Thrombosis Research|April 1, 1994
Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivoD S Houston, M R Buchanan
Advances in Experimental Medicine and Biology|January 1, 1997
Effects of linoleic acid and/or marine fish oil supplements on vessel wall thromboresistance in patients undergoing cardiac surgeryS J Brister, M R Buchanan
Annals of the New York Academy of Sciences|January 1, 1982
Interactions of platelets and leukocytes with vascular endothelium: in vitro studiesM A Gimbrone, M R Buchanan
Advances in Experimental Medicine and Biology|January 1, 1997
Effects of 13-HODE and other momohydroxides on integrin/ligand binding: implications for cell cell interactionsM R Buchanan, S J Brister
Thrombosis Research|February 15, 1983
Basal 6 keto PGF1 alpha levels: influence of sampling techniquesR W Butt, M R Buchanan
Seminars in Thrombosis and Hemostasis|January 1, 1993
Altering vessel wall fatty acid metabolism: a new strategy for antithrombotic treatmentM R Buchanan, S J Brister
Thrombosis Research|September 7, 2000
Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonistM R Buchanan, S J Brister
Pageof 14